SCHEMBL1710102

SCHEMBL1710102

COCCOc1ccc(C)c(OCCOC)c1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
INPPL1 O15357 1/20 0.43
TDP1 Q9NUW8 4/20 0.43
L3MBTL1 Q9Y468 2/20 0.43
MAOA P21397 1/20 0.42
DYRK1A Q13627 1/20 0.42
HPGD P15428 1/20 0.42
TSHR P16473 1/20 0.41
MAPT P10636 2/20 0.40
KDM4E B2RXH2 2/20 0.40
CYP1A2 P05177 1/20 0.40
CYP3A4 P08684 1/20 0.40
CYP2D6 P10635 1/20 0.40
CYP2C19 P33261 1/20 0.40
GAA P10253 1/20 0.40
MAPK1 P28482 1/20 0.39
DRD2 P14416 2/20 0.38
DRD4 P21917 2/20 0.38
DRD3 P35462 2/20 0.38
BRD4 O60885 1/20 0.38
CCL2 P13500 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20748335 0.92 INPPL1 (0.41) INPPL1TDP1L3MBTL1MAOADYRK1A
SCHEMBL8251636 0.91 L3MBTL1 (0.45) INPPL1TDP1L3MBTL1MAOADYRK1A
SCHEMBL8256675 0.84 HPGD (0.55) TDP1L3MBTL1MAOADYRK1AHPGD
SCHEMBL13475556 0.82 TSHR (0.59) TDP1L3MBTL1HPGDTSHRMAPT
SCHEMBL25526174 0.82 PTGS1 (0.46) MAOAHPGDTSHRMAPTKDM4E
SCHEMBL10717739 0.82 TSHR (0.46) L3MBTL1TSHRMAPTKDM4ECYP1A2
SCHEMBL13490814 0.81 TDP1 (0.44) TDP1L3MBTL1HPGDTSHRMAPT
SCHEMBL8251459 0.81 MRGPRX4 (0.46) TDP1MAOADYRK1AHPGDKDM4E
SCHEMBL454009 0.81 KDM4E (0.45) TSHRMAPTKDM4ECYP1A2CYP3A4
SCHEMBL10458232 0.81 TSHR (0.45) TDP1TSHRMAPTKDM4ECYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 24 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11693310-B2 Blue curable resin composition, blue color filter, and display device including same SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2023-07-04 US disclosed
US-11693310-B2 Blue curable resin composition, blue color filter, and display device including same SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2023-07-04 US disclosed
US-11209733-B2 Oxime ester photoinitiators BASF SE 2021-12-28 US disclosed
US-11209734-B2 Oxime ester photoinitiators BASF SE 2021-12-28 US disclosed
US-11204554-B2 Oxime ester photoinitiators BASF SE 2021-12-21 US disclosed
US-10488756-B2 Oxime ester photoinitiators BASF SE (DE) 2019-11-26 US disclosed
EP-3354641-B1 OXIME ESTER PHOTOINITIATORS BASF SE (DE) 2019-07-17 EP disclosed
EP-2847167-B1 OXIME ESTER PHOTOINITIATORS BASF SE (DE) 2018-07-18 EP disclosed
EP-2963015-B1 OXIME ESTER PHOTOINITIATORS BASF SE (DE) 2018-07-11 EP disclosed
US-9864273-B2 Oxime ester photoinitiators BASF SE (DE) 2018-01-09 US disclosed
EP-2963015-A1 OXIME ESTER PHOTOINITIATORS BASF SE (DE) 2016-01-06 EP disclosed
EP-2963014-A1 OXIME ESTER PHOTOINITIATORS BASF SE (DE) 2016-01-06 EP disclosed
EP-2963016-A1 OXIME ESTER PHOTOINITIATORS BASF SE (DE) 2016-01-06 EP disclosed
US-9051397-B2 Oxime ester BASF SE (DE) 2015-06-09 US disclosed
US-9051397-B2 Oxime ester BASF SE (DE) 2015-06-09 US disclosed
US-20150064624-A1 OXIME ESTER PHOTOINITIATORS BASF SE (DE) 2015-03-05 US disclosed
EP-2625166-B1 OXIME ESTER DERIVATIVES OF BENZOCARBAZOLE COMPOUNDS AND THEIR USE AS PHOTOINITIATORS IN PHOTOPOLYMERIZABLE COMPOSITIONS BASF SE (DE) 2014-09-24 EP disclosed
US-20130188270-A1 OXIME ESTER BASF SE (DE) 2013-07-25 US disclosed
US-20130188270-A1 OXIME ESTER BASF SE (DE) 2013-07-25 US disclosed
WO-2012045736-A1 OXIME ESTER DERIVATIVES OF BENZOCARBAZOLE COMPOUNDS AND THEIR USE AS PHOTOINITIATORS IN PHOTOPOLYMERIZABLE COMPOSITIONS BASF SE (DE) 2012-04-12 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11209734-B2 Oxime ester photoinitiators OR10J3, OXER1, QSOX1 INPPL1 3443/4885TDP1 3327/4885L3MBTL1 1060/4885
US-10488756-B2 Oxime ester photoinitiators OR10J3, OXER1, QSOX1 INPPL1 3443/4885TDP1 3327/4885L3MBTL1 1060/4885
US-11204554-B2 Oxime ester photoinitiators OR10J3, OXER1, QSOX1 INPPL1 3391/4885TDP1 3339/4885L3MBTL1 1093/4885
US-20130188270-A1 OXIME ESTER CBR3, CBR1, COX15 INPPL1 4685/4885TDP1 3314/4885L3MBTL1 752/4885
US-11209733-B2 Oxime ester photoinitiators OR10J3, OXER1, QSOX1 INPPL1 3443/4885TDP1 3327/4885L3MBTL1 1060/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.